In breast cancer it was also demonstrated that CCL2 levels were higher in stromal cells derived from tumors compared to normal breast tissues and that fibroblast-derived CCL2 contributed to tumor growth and metastasis in vivo (82, 162). Here, CCL2 is linked to breast carcinoma.